Zusammenfassung
Bis heute gilt die chirurgische Koronarrevaskularisation als Therapieoption der Wahl für Patienten mit koronarer 3-Gefäßerkrankung und/oder Hauptstammstenose. Neue perkutane Stent- und Interventionstechnologien (PCI) und dabei insbesondere die Etablierung medikamentenbeschichteter Stents (DES) fordern die Bypassoperation jedoch seit mehreren Jahren als primäres Revaskularisationsverfahren für diese prognostisch relevanten Formen der KHK neu heraus. In den bislang verfügbaren randomisierten Vergleichsstudien zeigte sich eine Überlegenheit der Operation einheitlich bezüglich der Notwendigkeit einer erneuten Koronarintervention, während Überlebens- und Myokardinfarktraten lediglich einen Trend zugunsten der Operation ergaben. Größere Registerdaten belegen hingegen bislang auch bei diesen Formen der KHK weiterhin einen Überlebensvorteil der Operation gegenüber der PCI.
Im Rahmen der bislang größten an diesem Patientenkollektiv durchgeführten randomisierten Untersuchung, der SYNTAX-Studie, zeigte sich, dass die Operation der PCI bezüglich des kombinierten Endpunkts aus gravierenden kardialen und zerebrovaskulären Ereignissen innerhalb von bis zu zwei Jahren nach dem Eingriff weiterhin signifikant überlegen ist. Dies ist zwar überwiegend einer geringeren Inzidenz wiederholter Koronarinterventionen geschuldet, nach zwei Jahren aber auch durch eine geringere Myokardinfarktrate und eine niedrigere kardial bedingte Mortalität erkärt. Es zeichnet sich jedoch ein Trend ab, dass die PCI bei Patienten mit weniger komplexer KHK eine vergleichbare Behandlungsoption darstellen könnte, wohingegen aber Patienten mit komplexer Koronarpathologie unverändert eindeutig von der Bypassoperation profitieren. Die Ergebnisse der SYNTAX-Studie werden derzeit intensiv innerhalb und zwischen den verschiedenen Fachgesellschaften diskutiert und haben Leitliniendiskussionen angestoßen, deren abschließende Bewertung abgewartet werden muss.
Abstract
Coronary artery bypass graft surgery (CABG) is still considered to be the standard of care for patients with a prognostically relevant pattern of coronary artery disease. New stent designs, including drug-eluting stents (DES) and improvements in percutaneous coronary intervention (PCI) technologies during recent years, challenge CABG in the treatment of coronary three-vessel disease and/or left main stem stenosis. To date, randomized trials have demonstrated significantly higher repeat revascularization rates in PCI patients but comparable results regarding procedural and mid-term survival as well as adverse events like myocardial infarction. In contrast, real world registry data demonstrated a survival benefit of CABG over PCI as the primary treatment option.
Recently, 2-year results of the largest comparative randomized trial to date, the SYNTAX trial, were made available. These data demonstrated the superiority of CABG over PCI regarding the combined endpoint of death and major adverse cardiac and cerebrovascular events, including repeat revascularization. There were comparable results in patients with less complex coronary artery disease between PCI and CABG, while patients with more complex coronary pathologies had significantly better results after surgical intervention. These results have led to controversies in all major medical societies and have resulted in intensive and ongoing guideline discussions.
Literatur
Babapulle MN, Joseph L, Belisle P et al (2004) A hierarchical Bayesian meta-analysis of randomized trials of drug-eluting stents. Lancet 364:583–591
Booth J, Clayton T, Pepper J et al (2008) Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease. Six-year follow-up from the Stent or Surgery trial (SoS). Circulation 118:381–388
Boudriot E (2009) Randomized, multicenter trial between PCI with Sirolimus-eluting stent versus CABG for unprotected left main coronary disease (2009). Presented at the EuroPCR meeting, Barcelona, Spain
Bravata DM, Ginger AL, MacDonald KM et al (2007) Systematic review: The comparative effectiveness of percutaneous coronary interventions and coronary bypass graft surgery. Ann Intern Med 147:703–716
Buszman PE, Kiesz SR, Bochenek A et al (2008) Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol 51:538–545
Bypass Angioplasty Revascularization Investigation (BARI) Investigators (1996) Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335:217–225
Daemen J, Boersma E, Flather M et al (2008) Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease. Circulation 118:1146–1154
Eagle KA, Guyton RA, Davidoff R et al (2004) ACA/AHA 2004 guideline update for coronary artery bypass graft surgery. Circulation 110:e340–e437
Grüntzig A (1978) Transluminal dilatation of coronary artery stenosis. Lancet 1:263
Gummert JF, Funkat A, Beckmann A et al (2009) Cardiac surgery in Germany during 2008. A report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 57:315–323
Hannan EL, Racz MJ, Walford G et al (2005) Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 352:2174–2183
Hannan EL, Wu C, Walford G et al (2008) Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 358:331–341
Hlatky MA, Boothroyd DB, Bravata DM et al (2009) Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 373:1190–1197
Hoffmann SN, TenBrook JA, Wolf MP et al (2003) A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 41:1293–1304
Hueb W, Lopes NH, Gersh BJ et al (2007) Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II). A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 115:1082–1189
Kappetein AP, Dawkins KD, Mohr FW et al (2006) Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase. Eur J Cardiothorac Surg 29:486–491
Kappetein AP (2009) Optimal revascularization strategy in patients with three-vessel disease and/or left main disease. The 2-year outcomes of the SYNTAX-Trial. Presented at the ESC meeting 2009, Barcelona, Spain
Katritsis DG, George CM, Ioannidis JPA et al (2009) Double versus single stenting for coronary bypass lesions: A meta-analysis. Circ Cardiovasc Interv 2:409–415
Malenka DJ, Leavitt BJ, Hearne MJ et al (2005) Northern New England Cardiovascular Disease Study Group. Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northern New England. Circulation 112:371–376
Massoudy P, Thielmann M, Lehmann N et al (2009) Impact of prior percutaneous coronary intervention on the outcome of coronary artery bypass surgery: a multicenter analysis. Thorac Cardiovasc Surg 137:840–845
Mauri L, Hsieh WH, Massaro JM et al (2007) Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356:1020–1029
Moses JW, Leon MB, Popma JJ et al (2003) Sirolimus-elutung stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315–1323
Patel MR, Dehmer GJ, Hirshfeld JW et al (2009). ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology: Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. Circulation 119:1330–1352
Puskas J, Cheng D, Knight J et al (2005) Off-pump versus conventional coronary artery bypass grafting: A meta-analysis and consensus statement from the 2004 ISMICS consensus conference. Innovation 1:3–27
Rastan AJ, Boudriot E, Falk V et al (2008) Frequency and pattern of de-novo three-vessel and left main coronary artery disease – Insights from a single center SYNTAX study enrolment. Eur J Cardiothoracic Surg 34:376–383
Rodriguez AE, Baldi J, Pereira CF et al (2005) Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol 46:582–588
Serruys P (2008) SYNTAX-Trial 12-month outcomes in subset of patients with left main disease. Data presented at the TCT meeting 2008, Washington, USA
Serruys PW, Maurice M-C, Kappetein AP et al (2009) Percutaneous coronary intervention versus coronary artery bypass grafting for severe coronary artery disease. N Engl J Med 360:961–972
Serruys PW, Ong ATL, Herwerden LA van et al (2005) Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease. The final analysis of the Arterial Revascularization Therapies (ARTS) randomized trial. J Am Coll Cardiol 46:575–581
Serruys PW, Onuma Y, Garg S et al (2009) Assessment of the SYNTAX score in the SYNTAX study. EuroIntervention 5:50–56
Seung KB, Park DW, Kim YH et al (2008) Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 358:1781–1792
Silber S, Albertsson P, Avilés FF et al (2005) Task force for percutaneous coronary interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J 26:804–847
Taggart DP, Kaul S, Boden WE et al (2008) Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery. J Am Coll Cardiol 51:885–892
Valgimigli M, Serruys PW, Tsuchida K et al (2007) Cyphering the complexity of coronary artery disease using the SYNTAX™ score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol 99:1072–1081
Yusuf S, Zucker D, Peduzzi P et al (1994) Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344:563–570
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mohr, F., Rastan, A., Cremer, J. et al. Die Bedeutung der SYNTAX-Studie für die moderne Koronarchirurgie. Z Herz- Thorax- Gefäßchir 24, 49–57 (2010). https://doi.org/10.1007/s00398-009-0761-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00398-009-0761-6